Results 241 to 250 of about 17,468,048 (391)

Laboratory Wise Variations in Prothrombin Time - INR - A Cross Sectional Study in Trivandrum, Kerala

, 2021
Shahana Jahan Kulathinte Meethal, Ravikrishnan Jayakumar, Suresh Kumar Sreenivasan, Shaffeek Abdul Majeed, Indira Kariveettil   +4 more
openalex   +1 more source

Normal prothrombin time in the presence of therapeutic levels of rivaroxaban

British Journal of Haematology, 2013
J. J. Veen, Julie M. Smith, S. Kitchen, M. Makris   +3 more
semanticscholar   +1 more source

Measuring Direct Oral Anticoagulant (DOAC) Levels: Applications, Limitations, and Future Directions

International Journal of Laboratory Hematology, EarlyView.
ABSTRACT Introduction There are important challenges with the measurement and interpretation of direct oral anticoagulant (DOAC) anticoagulant effect including a lack of therapeutic ranges, inaccuracy of routinely available coagulation assays, lack of established thresholds for clinically significant effect, and uncertainty about how to apply the ...
Siraj Mithoowani, Chee Wee Tan, Deborah M. Siegal   +2 more
wiley   +1 more source

Role of Electrode Configuration and Morphology in Printed Prothrombin Time Sensors. [PDF]

Sens Actuators B Chem
Huegen BL, Doherty JL, Smith BN, Franklin AD.   +3 more
europepmc   +1 more source

Assessment of Stability of Prothrombin Time, International Normalized Ratio, and Activated Partial Thromboplastin Time Under Different Storage Conditions in Human Plasma. [PDF]

Cureus, 2022
Patil P, Sehgal T, Goswami P, Gaur M, Khan M, Pandey S, Datta SK.   +6 more
europepmc   +1 more source

Clinical heterotransplantation of the liver. [PDF]

, 1970
Amemiya, H, Boehmig, HJ, Giles, GR, Halgrimson, CG, Starzl, TE   +4 more
core  

Prognostic value of prothrombin time and activated partial thromboplastin time in patients with posttraumatic disseminated intravascular coagulation.

, 1994
Satoshi Gando, Satoshi Nanzaki, Takashi Kameue, Hiroshi Makise, Yoshimi Nakanishi   +4 more
openalex   +2 more sources

Evaluation of the prothrombin time for measuring rivaroxaban plasma concentrations using calibrators and controls

Clinical and applied thrombosis/hemostasis, 2012
M. Samama, Genevieve Contant, Theodore E. Spiro, Elisabeth Perzborn, L. Flem, C. Guinet, Yves Gourmelin, J. Martinoli   +7 more
semanticscholar   +1 more source

Classification of Platelet‐Activating Anti‐Platelet Factor 4 Disorders

International Journal of Laboratory Hematology, EarlyView.
ABSTRACT Introduction The prototypic anti‐platelet factor 4 (PF4) disorder—heparin‐induced thrombocytopenia and thrombosis (HITT)—features immunoglobulin G (IgG) class antibodies that activate platelets, monocytes, and neutrophils in a mainly heparin‐dependent fashion via Fcγ receptor‐dependent cellular activation.
Theodore E. Warkentin
wiley   +1 more source

Association of prothrombin time, thrombin time and activated partial thromboplastin time levels with preeclampsia: a systematic review and meta-analysis. [PDF]

BMC Pregnancy Childbirth
Alemayehu E, Mohammed O, Belete MA, Mulatie Z, Debash H, Gedefie A, Weldehanna DG, Eshetu B, Shibabaw A, Tekele SG, Tilahun M, Ebrahim H.   +11 more
europepmc   +1 more source